Health behaviours such as poor diet, physical inactivity, excessive alcohol consumption and smoking play key roles in the development and progression of lifestyle related Non-Communicable Diseases (NCDs) like obesity, which is an important contributor to cardiovascular disease. Like many NCDs, obesity is modifiable and can be brought into remission through lifestyle interventions including maintaining a healthy diet and body weight, engaging in moderate to vigorous physical activity, reducing alcohol consumption and abstaining from tobacco smoking. Many lifestyle intervention programmes under the umbrella of social prescriptions have been developed to help people who have or are at risk of this condition. While clinical trials have pointed towards beneficial effects of lifestyle intervention, they may not fully capture real life and longitudinal effects of these interventions. It is also important to determine whether different patient groups (by sex, age, socioeconomic status and underlying health conditions) benefit from lifestyle intervention programs to the same extent. Finally, it is not known how often lifestyle interventions are used as a first line option in practice by GPs. This study focusses on the use and real-life effectiveness of lifestyle intervention programmes in primary care. Because of the large number of patients included in CPRD (Clinical Practice Research Datalink) and the extensive time horizon during which these patients were observed, we will be able to study immediate benefits and long-run effects for both men and women. Given the promising use of lifestyle intervention, the results of this study have direct implications for clinical care and population health.
This study focusses on the patterns of use and real-life effectiveness of lifestyle intervention programmes in UK primary care. Previous studies investigating the health effects of lifestyle intervention administered to people diagnosed with obesity are largely limited to controlled clinical trials and small-scale observational studies. First, this study seeks to explore the use of lifestyle interventions in UK primary care in adherence to current guidelines for obesity, for which they are recommended as a first line option, by studying the proportion of patients who received a structured lifestyle intervention upon their diagnosis of obesity. Second, while previous studies have pointed towards the efficacy of lifestyle interventions in improving key health outcomes, they might not be able to fully capture treatment effectiveness during routine care and frequently lack the necessary time horizon to study long-run benefits and risks. Thus, we aim to explore the effect of lifestyle intervention on short-, mid-, and long-term physical and behavioral outcomes in a routine care set-up for adult men and adult women. Finally, we will test for heterogenous treatment effects by stratifying our sample by sex, age, socioeconomic status, ethnicity and comorbidities. The findings of this study are expected to provide novel insights into the use and effectiveness of lifestyle interventions in a real-life setting and can directly inform clinical practice.
Health Outcomes to be Measured:
We will explore the effects on the following primary outcomes:
- Blood cholesterol levels (HDL, LDL, total cholesterol)
- Blood pressure
- Smoking status
- Recorded hazardous alcohol consumption
We will also explore the following secondary outcomes
- Number of all-cause emergency hospitalizations
- Number of cardiovascular disease-related emergency hospitalizations
- Number of severe adverse health events (stroke, heart attack [myocardial infarction] – each event type evaluated separately)
- All-cause mortality
- Number of GP visits
- Number of medications
2011 Rural-Urban Classification at LSOA level;HES Admitted Patient Care;ONS Death Registration Data;Patient Level Index of Multiple Deprivation